<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The effects of nilvadipine, a <z:chebi fb="0" ids="29108">Ca2+</z:chebi> entry blocker, on focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> were investigated in rats having unilateral middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> rats had 24 h <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, and were divided into three groups (ten rats per group) </plain></SENT>
<SENT sid="2" pm="."><plain>Groups 1 and 2 received 1.0 and 3.2 mg/kg nilvadipine s.c. respectively, just after the occlusion </plain></SENT>
<SENT sid="3" pm="."><plain>Control rats received an equal volume of the vehicle </plain></SENT>
<SENT sid="4" pm="."><plain>Control animals had a % <z:mpath ids='MPATH_124'>infarct</z:mpath> volume of 28.2 +/- 11.4%, and a left/right hemispheric volume ratio of 112 +/- 12% </plain></SENT>
<SENT sid="5" pm="."><plain>Group-1 and -2 rats had % <z:mpath ids='MPATH_124'>infarct</z:mpath> volumes of 25.5 +/- 11.6% and 13.9 +/- 9.2% (p less than 0.01) respectively, and left/right hemispheric volume ratios of 111 +/- 9% and 103 +/- 7% (p less than 0.05), respectively </plain></SENT>
<SENT sid="6" pm="."><plain>Thus, the drug reduced the <z:mpath ids='MPATH_124'>infarct</z:mpath> size and the <z:hpo ids='HP_0002181'>brain edema</z:hpo> in a dose-dependent manner </plain></SENT>
<SENT sid="7" pm="."><plain>The significant decrease in the <z:mpath ids='MPATH_124'>infarct</z:mpath> volume was observed in the periphery of the frontoparietal cortex </plain></SENT>
<SENT sid="8" pm="."><plain>This study supports the hypothesis that nilvadipine may be a potential therapeutic agent for <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>Neuropathological findings suggest the possible therapeutic effects of the drug in the ischemic penumbra </plain></SENT>
</text></document>